Edition:
United Kingdom

Wright Medical Group NV (WMGI.OQ)

WMGI.OQ on NASDAQ Stock Exchange Global Select Market

19.40USD
23 Apr 2018
Change (% chg)

$0.11 (+0.57%)
Prev Close
$19.29
Open
$19.31
Day's High
$19.53
Day's Low
$19.20
Volume
150,154
Avg. Vol
304,218
52-wk High
$30.91
52-wk Low
$19.05

Latest Key Developments (Source: Significant Developments)

Wright Medical Group ‍Q4 Net Sales $218 Million​
Tuesday, 27 Feb 2018 

Feb 27 (Reuters) - Wright Medical Group Nv ::WRIGHT MEDICAL GROUP N.V. REPORTS 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS AND PROVIDES 2018 ANNUAL GUIDANCE.Q4 EARNINGS PER SHARE $0.25 FROM CONTINUING OPERATIONS.SEES FY 2018 SALES ABOUT $800 MILLION TO $812 MILLION.SEES Q4 2017 SALES $217.6 MILLION.SEES Q4 2017 SALES UP 11.2 PERCENT.‍Q4 2017 NET SALES OF $218 MILLION​.  Full Article

Wright Medical Group Reports Q4 EPS $0.25 From Cont Ops
Tuesday, 27 Feb 2018 

Feb 27 (Reuters) - Wright Medical Group Nv ::WRIGHT MEDICAL GROUP N.V. REPORTS 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS AND PROVIDES 2018 ANNUAL GUIDANCE.REPORTS Q4 2017 SALES $217.6 MILLION.REPORTS Q4 2017 SALES UP 11.2 PERCENT.Q4 EARNINGS PER SHARE $0.25 FROM CONTINUING OPERATIONS.SEES FY 2018 SALES ABOUT $800 MILLION TO $812 MILLION.‍Q4 2017 NET SALES OF $218 MILLION​.  Full Article

Wright Medical Group buys IMASCAP SAS for $88.8 mln
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Wright Medical Group Nv ::WRIGHT MEDICAL GROUP N.V. ANNOUNCES ACQUISITION OF IMASCAP SAS.WRIGHT MEDICAL GROUP NV - DEAL FOR EUR 75.1 MILLION, OR APPROXIMATELY $88.8 MILLION.WRIGHT MEDICAL GROUP NV - COMPANY REITERATES PREVIOUSLY PROVIDED 2017 ANNUAL FINANCIAL GUIDANCE.WRIGHT MEDICAL GROUP - DEAL CONSIDERATION CONSISTS OF ABOUT $46.9 MILLION IN CASH AND ABOUT $15.6 MILLION OF CO'S SHARES.WRIGHT MEDICAL GROUP - DEAL CONSIDERATION ALSO CONSISTS OF ABOUT $26.3 MILLION IN POTENTIAL EARNOUTS AND MILESTONE PAYMENTS.  Full Article

Wright Medical Q3 loss per share $0.33 from continuing operations
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Wright Medical Group Nv ::Wright medical group n.v. Reports 2017 third quarter financial results and updated 2017 annual guidance.Q3 loss per share $0.33 from continuing operations.Q3 sales $170.5 million.Sees fy 2017 sales $740 million to $745 million.Wright medical group nv - ‍increases full-year 2017 non-gaap adjusted ebitda guidance to $84 million to $88 million​.Wright medical group nv - sees ‍non-gaap loss per share from continuing operations for full-year 2017 to be $0.28 to $0.24​.  Full Article

Wright Medical Group ‍agreed on a comprehensive settlement intended to resolve substantially all remaining metal-on-metal hip claims
Wednesday, 4 Oct 2017 

Oct 4 (Reuters) - Wright Medical Group Nv ::Wright Medical Group - on October 3, co ‍agreed on a comprehensive settlement intended to resolve substantially all remaining metal-on-metal hip claims.Wright Medical Group - remaining claims pending or tolled were not settled in previously disclosed master settlement agreement dated Nov 2, 2016.Says ‍maximum liability under settlement agreements will not exceed $89.75 million​.Wright Medical Group NV - ‍comprehensive settlement totals at least $35 million​.  Full Article

Wright Medical Group N.V. Q2 loss per share $0.20
Wednesday, 2 Aug 2017 

Aug 2 (Reuters) - Wright Medical Group Nv :Wright Medical Group N.V. reports 2017 second quarter financial results.Q2 loss per share $0.20 from continuing operations.Sees FY 2017 sales about $755 million to $765 million.Q2 sales rose 6 percent to $179.7 million.Wright Medical Group N.V. says reaffirms previously provided 2017 annual guidance.Q2 earnings per share view $-0.09, revenue view $178.2 million -- Thomson Reuters I/B/E/S.FY 2017 earnings per share view $-0.30, revenue view $758.4 million -- Thomson Reuters I/B/E/S.  Full Article

Wright Medical Group Q1 loss per share $0.35 from cont ops
Wednesday, 3 May 2017 

May 3 (Reuters) - Wright Medical Group Nv ::Wright Medical Group N.V. Reports 2017 first quarter financial results.Q1 loss per share $0.35 from continuing operations.Sees fy 2017 sales about $755 million to $765 million.Q1 sales rose 6 percent to $177.2 million.Wright medical group nv says reaffirms previously provided 2017 annual guidance.Fy2017 earnings per share view $-0.29, revenue view $762.8 million -- Thomson Reuters I/B/E/S.  Full Article

Wright MEDICAL GROUP N.V. reports Q4 sales $193 million
Tuesday, 21 Feb 2017 

Wright Medical Group NV : Wright Medical Group N.V. Reports 2016 fourth quarter and full-year financial results and provides 2017 guidance . Q4 loss per share $0.29 from continuing operations . Sees fy 2017 sales $755 million to $765 million . Q4 sales $193 million .Sees 2017 non-GAAP adjusted ebitda from continuing operations of $78.5 million to $85.5 million.  Full Article

Wright Medical Group says Q2 loss per share $0.41 from continuing operations
Wednesday, 3 Aug 2016 

Wright Medical Group Nv : Wright medical group n.v. Reports 2016 second quarter financial results and increases 2016 guidance . Q2 sales $171 million . Q2 loss per share $0.41 from continuing operations . Sees fy 2016 sales $675 million to $685 million . Fy2016 earnings per share view $-0.61, revenue view $713.1 million -- Thomson Reuters I/B/E/S . Sees full-year 2016 non-gaap adjusted ebitda from continuing operations $40 million to $45 million . Anticipates adjusted cash loss per share from continuing operations for full-year 2016 of $0.54 to $0.47 .Q2 earnings per share view $-0.22, revenue view $172.5 million -- Thomson Reuters I/B/E/S.  Full Article

Wright Medical Group says Q2 loss per share $0.41 from continuing operations
Tuesday, 2 Aug 2016 

Wright Medical Group Nv : Wright medical group n.v. Reports 2016 second quarter financial results and increases 2016 guidance . Q2 sales $171 million . Q2 loss per share $0.41 from continuing operations . Sees fy 2016 sales $675 million to $685 million . Fy2016 earnings per share view $-0.61, revenue view $713.1 million -- Thomson Reuters I/B/E/S . Sees full-year 2016 non-gaap adjusted ebitda from continuing operations $40 million to $45 million . Anticipates adjusted cash loss per share from continuing operations for full-year 2016 of $0.54 to $0.47 .Q2 earnings per share view $-0.22, revenue view $172.5 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Wright Medical Group Reports Q4 EPS $0.25 From Cont Ops

* WRIGHT MEDICAL GROUP N.V. REPORTS 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS AND PROVIDES 2018 ANNUAL GUIDANCE